Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Hormones – e.g. – prolactin – thymosin – growth factors – etc.
Reexamination Certificate
2007-02-06
2007-02-06
Romeo, David S (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Hormones, e.g., prolactin, thymosin, growth factors, etc.
C530S397000, C530S398000, C514S012200
Reexamination Certificate
active
10119427
ABSTRACT:
This invention provides VEGF-FSH compounds having increased serum half-lives relative to either native VEGF or FSH, in which both VEGF and FSH are biologically active. This invention also provides related compositions and methods for increasing fertility, egg production and spermatogenesis in a subject, as well as methods for increasing vascularization in a tissue, particularly in ovarian tissue.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 5585345 (1996-12-01), Boime
patent: 5759818 (1998-06-01), Boime
patent: 5958737 (1999-09-01), Boime et al.
patent: 5985611 (1999-11-01), Boime
patent: 6040157 (2000-03-01), Hu et al.
patent: 6225449 (2001-05-01), Boime
patent: 6242580 (2001-06-01), Boime et al.
patent: 6306654 (2001-10-01), Boime et al.
Bouloux, P. M., D. J. Handelsman, F. Jockenhovel, E. Nieschlag, J. Rabinovici, W. L. Frasa, J. J. de Bie, G. Voortman, and J. Itskovitz-Eldor (2001) First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.Hum. Reprod. 16, 1592-1597 (Exhibit 7).
Calvo, F. O., H. T. Keutmann, E. R. Bergert, and R. J. Ryan (1986) Deglycosylated human follitropin: characterization and effects on adenosine cyclic 3′,5′—phosphate production in porcine granulosa cells.Biochemistry25, 3938-3943 (Exhibit 8).
Chui, D. K., N. D. Pugh, S. M. Walker, L. Gregory, and R. W. Shaw (1997) Follicular vascularity—the predictive value of transvaginal power Doppler ultrasonography in an in vitro fertilization programme: a preliminary study.Hum. Reprod. 12, 191-196 (Exhibit 9).
Dissen, G. A., H. E. Lara, W. H. Fahrenbach, M. E. Costa, and S. R. Ojeda (1994) Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression.Endocrinology134, 1146-1154 (Exhibit 10).
Fares, F. A., N. Suganuma, K. Nishimori, P. S. Lapolt, A. J. Hsueh, and I. Boime (1992) Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.Proc. Natl. Acad. Sci. U.S.A. 89, 4304-4308 (Exhibit 11).
Feng, W., M. M. Matzuk, K. Mountjoy, E. Bedows, R. W. Ruddon, and I. Boime (1995) The asparagine-linked oligosaccharides of the human chorionic gonadotropin beta subunit facilitate correct disulfide bond pairing.J. Biol. Chem. 270, 11851-11859 (Exhibit 12).
Ferrara, N., H. Chen, T. Davis-Smyth, H. P. Gerber, T. N. Nguyen, D. Peers, V. Chisholm, K. J. Hillan, and R. H. Schwall (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis.Nat. Med. 4, 336-340 (Exhibit 13).
Ferrara, N., K. Houck, L. Jakeman, and D. W. Leung (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins.Endocr. Rev. 13, 18-32 (Exhibit 14).
Krichevsky, A., S. Birken, J. F. O'Connor, K. Bikel, J. Schlatterer, and R. E. Canfield (1994) The development of a panel of monoclonal antibodies to human luteinizing hormone and its application to immunological mapping and two-site assays.Endocrine 2. 511-520 (Exhibit 15).
LeContonnec, J.Y., H.C. Porchet, V. Beltrami, A. Khan, S. Toon, and M. Rowland (1994) Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady-state pharmacokinetics.Fertil. Steril. 61, 679-86 (Exhibit 16).
Lindau-Shapard, B.A., H.A. Brumberg, A.J. Peterson, and J.A. Dias (2001) Reversible immunoneutralization of human follitropin receptor.J. Reprod. Immun. 49, 1-19 (Exhibit 17).
Matzuk, M. M., A. J. Hsueh, P. Lapolt, A. Tsafriri, J. L. Keene, and I. Boime (1990) The biological role of the carboxyl-terminal extension of human chorionic gonadotropin beta-subunit.Endocrinology126, 376-383 (Exhibit 18).
Nargund, G., T. Bourne, P. Doyle, J. Parsons, W. Cheng, S. Campbell, and W. Collins (1996) Associations between ultrasound indices of follicular blood flow, oocyte recovery and preimplantation embryo quality.Hum. Reprod. 11, 109-113 (Exhibit 19).
Pedersen, T. and H. Peters (1968) Proposal for a classification of oocytes and follicles in the mouse ovary.J. Reprod. Fertil. 17, 555-557 (Exhibit 20).
Pierce, J. G. and T. F. Parsons (1981) Glycoprotein hormones: structure and function.Annu. Rev. Biochem. 50, 465-495 (Exhibit 21).
Porchet, H.C., J.Y. LeContonnec, B. Neuteboom, S. Canali, and G. Zanolo (1995) Pharmacokinetics of recombinant human luteinizing hormone.J. Clin. Endocrinol. Metab. 80, 667-73 (Exhibit 22).
Saal, W., H.J. Glowania, and J. Happ (1991) Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin.Fertil. Steril. 56, 225-8 (Exhibit 23).
Sairam, M. R. and P. Manjunath (1982) Studies on pituitary follitropin. XL Induction of hormonal antagonistic activity by chemical deglycosylation.Mol. Cell Endocrinol. 28, 139-150 (Exhibit 24).
Sugahara, T., M. R. Pixley, F. Fares, and I. Boime (1996) Characterization of the O-glycosylation sites in the chorionic gonadotropin beta subunit in vivo using site-directed mutagenesis and gene transfer.J. Biol. Chem. 271, 20797-20804 (Exhibit 25).
Suganuma, N., M. M. Matzuk, and I. Boime (1989) Elimination of disulfide bonds affects assembly and secretion of the human chorionic gonadotropin beta subunit.J. Biol. Chem. 264, 19302-19307 (Exhibit 26).
Van Blerkom, J., M. Antczak, and R. Schrader (1997) The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics.Hum. Reprod. 12, 1047-1055 (Exhibit 27); and.
Yen, S. S., O. Llerena, B. Little, and O. H. Pearson (1968) Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man.J. Clin. Endocrinol. Metab. 28, 1763-1767 (Exhibit 28).
International Search Report issued Dec. 1, 2003 in connection with PCT International Application No. PCT/US03/02982: and.
Ben-Menahem et al. (2001) The Position of the Alpha and Beta Subunits in a Single Chain Variant of Human Chorionic Gonadotropin Affects the Heterodimeric Interaction of the Subunits and Receptor-Binding Epitope. J. Biol. Chem. 276:29871-879.
Lobel Leslie
Lustbader Joyce
Cooper & Dunham LLP
Gamett Daniel C
Romeo David S
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Long-acting hormone and growth factor compositions and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long-acting hormone and growth factor compositions and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long-acting hormone and growth factor compositions and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3862172